Serge Gauthier
CHAIRMAN
Board of Directors
TauRx Therapeutics
Singapore
Biography
Dr Gauthier is credited with setting up the first multicentre Canadian study of tacrine as a treatment for Alzheimer's disease, as well as with creating the Consortium of Canadian Centres for Clinical Cognitive Research (C5R). Director of the Alzheimer’s Disease Research Unit, McGill Centre for Studies in Ageing, Quebec, Canada, he is famous for his outstanding contributions to the development of new diagnostic and therapeutic approaches to Alzheimer's disease and other disorders of dementia.
Research Interest
Development of new diagnostic and therapeutic approaches to Alzheimer's disease and other disorders of dementia
